Healthcare Providers

Bristol-Myers Squibb provides the following information and resources for healthcare professionals, to assist with caring for patients and researching innovative medicines.


Medicine vials

Our Medicines

Our mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases.


Pharmacovigilance Notice

This website has not been designed to collect safety information related to Bristol-Myers Squibb products.

Healthcare Professionals  

Reporting of suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via Freepost, HPRA Pharmacovigilance, Earlsfort Terrace, IRL - Dublin 2; Tel: +353 1 6764971; Fax: +353 1 6762517. Website: www.hpra.ie; E-mail: medsafety@hpra.ie

Adverse reactions should also be reported to Bristol-Myers Squibb Medical Information on 1 800 749 749 or medical.information@bms.com

Patients  

Reporting of side effects: If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via Freepost, HPRA Pharmacovigilance, Earlsfort Terrace, IRL - Dublin 2; Tel: +353 1 6764971; Fax: +353 1 6762517. Website: www.hpra.ie; E-mail: medsafety@hpra.ie. By reporting side effects you can help provide more information on the safety of this medicine.

Side effects should also be reported to Bristol-Myers Squibb Medical Information on 1 800 749 749 or medical.information@bms.com

Healthcare professionals and patients should also report Product Quality Complaints to Bristol-Myers Squibb Medical Information on 1 800 749 749 or medical.information@bms.com


Scientist with a microscope

Researchers & Partners

Find out how we're discovering and developing investigational medicines for patients.
Scientist filling a vial

Independent Research

Bristol-Myers Squibb wishes to advance science through supporting novel, independent research that addresses unmet needs surrounding our products and therapeutic areas.

We consider requests from independent investigators who share our goal.


Man drawing on a dry-erase board

Transparency

We are committed to conducting business with the highest integrity and will continue to increase transparency so we can share information with our patients, peers, and shareholders.

Approval number: MLTIE1706439-01
Date: May 2018